Mankind Pharma Limited (NSE:MANKIND)
India
· Delayed Price · Currency is INR 2,163.30
-23.70 (-1.08%)
At close: Mar 9, 2026
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 893.02 billion as of March 9, 2026. Its market cap has decreased by -13.46% in one year.
Market Cap
893.02B
Enterprise Value
944.15B
Revenue
139.14B
Ranking
n/a
PE Ratio
50.07
Stock Price
2,163.30
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 893.02B, an increase of 56.74%. That is a compound annual growth rate of 17.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 902.80B | -0.43% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1,188.36B | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 918.74B |
| Cipla | 1,067.24B |
| Aurobindo Pharma | 715.49B |
| Alkem Laboratories | 661.19B |
| Glenmark Pharmaceuticals | 599.51B |
| Laurus Labs | 554.00B |
| Divi's Laboratories | 1,680.15B |
| Ipca Laboratories | 379.08B |